No takes yet. Share an insight, caveat, or question.
Narrative review highlights topoisomerase II targeting and structure-activity relationships of anthracyclines, indicating novel synthetic strategies to overcome drug resistance and toxicity.
Binaschi et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: